PediatricsNews.net

Pediatrics Xagena

Multiple studies have confirmed associations between acid suppression medication and Clostridium difficile infections ( CDIs ) in adults. Therefore, researchers sought to evaluate an association betwe ...


Children with Crohn’s disease often have impaired growth. The IMAgINE 1 trial demonstrated the safety and effectiveness of Adalimumab ( Humira ) on inducing and maintaining remission in children with ...


The FDA ( Food and Drug Administration ) has approved a new indication for Adalimumab ( Humira ) for the treatment of moderate to severe Crohn’s disease n pediatric patients 6 years of age and older. ...


Researchers have examined the risk for persistent pulmonary hypertension of the newborn associated with antenatal exposure to antidepressants. A systematic review and meta-analysis was performed. ...


The objective of the study was to examine whether first trimester fetal growth restriction correlates with cardiovascular outcomes in childhood. The population-based prospective cohort study has en ...


Autism involves early brain overgrowth and dysfunction, which is most strongly evident in the prefrontal cortex. As assessed on pathological analysis, an excess of neurons in the prefrontal cortex amo ...


Paracetamol ( Acetaminophen ) when used appropriately, it is considered mostly harmless. Over recent decades, the drug, which has been marketed since the 1950s, has become the medication most commonly ...


Kawasaki disease ( KD ) is a severe childhood disease that many parents mistake for an inconsequential viral infection. If not diagnosed or treated in time, it can lead to irreversible heart damage.Si ...


Adalimumab ( Humira ), a humanized anti-tumour necrosis factor antibody, is an effective treatment in adult patients with refractory Crohn's disease. The available literature on its efficacy in chil ...


The efficacy and safety / tolerability of adjunctive Zonisamide ( Zonegran ) treatment in pediatric patients with partial epilepsy, was assessed. In this phase III, double-blind, randomized, placeb ...


Neonatal hypoglycaemia is common, and a preventable cause of brain damage. Dextrose gel is used to reverse hypoglycaemia in individuals with diabetes; however, little evidence exists for its use in ba ...


To reduce the risk of bronchopulmonary dysplasia in extremely-low-birth-weight infants, clinicians attempt to minimize the use of endotracheal intubation by the early introduction of less invasive for ...


Severe acute malnutrition contributes to 1 million deaths among children annually. Adding routine antibiotic agents to nutritional therapy may increase recovery rates and decrease mortality among chil ...


Although the survival of children and adolescents with malignant germ-cell tumours has improved greatly in recent years, the outcome remains poor for those with refractory or recurrent malignant germ- ...


Codeine should only be used to relieve acute moderate pain in children older than 12 years and only if it cannot be relieved by other painkillers such as Paracetamol or Ibuprofen alone.Furthermore, a ...


Multiple courses of prenatal corticosteroids, compared with a single course, taken by pregnant women to help prevent preterm birth was associated with no increase or decrease in the risk of death or d ...


A St. Jude Children's research has found that childhood cancer survivors overwhelmingly experience a significant amount of undiagnosed, serious disease through their adult years, establishing the impo ...


Researchers from Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Brigham and Women's Hospital, led by Sara Barton of Brigham and Women's Hospital, Boston, USA, surveyed participant ...


Researchers from the University of Minnesota College of Pharmacy have provided the first evidence-based data on changes in drug metabolism in obese children as compared to healthy weight children. ...


Even children of a healthy weight who have an imbalanced metabolism due to poor diet or exercise may be at increased risk of asthma, according to new research, which challenges the widespread assumpti ...



2000-2014© XAGENA srl - P.IVA: 04454930969 - REA: 1748680 - Tutti i diritti riservati